Now showing items 1-3 of 3

    • Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. 

      Bidlingmaier, M; Cummings, DE; D'Alessio, David A; Davis, HW; Kahn, SE; Prigeon, RL; Tong, Jenny; ... (8 authors) (Diabetes, 2010-09)
      OBJECTIVE: The orexigenic gut hormone ghrelin and its receptor are present in pancreatic islets. Although ghrelin reduces insulin secretion in rodents, its effect on insulin secretion in humans has not been established. ...
    • Ghrelin. 

      Andermann, ML; Andrews, ZB; Anker, SD; Argente, J; Batterham, RL; Benoit, SC; Bowers, CY; ... (57 authors) (Mol Metab, 2015-06)
      BACKGROUND: The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the endogenous ligand of the growth hormone secretagogue receptor. Increasing evidence supports more complicated and nuanced roles for the ...
    • Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study. 

      Cai, Yi; Carlozzi, NE; Cummings, DE; DeWalt, DA; Gbadegesin, Rasheed Adebayo; Gipson, DS; Goebel, J; ... (24 authors) (Health Qual Life Outcomes, 2017-08-23)
      BACKGROUND: Nephrotic syndrome represents a condition in pediatric nephrology typified by a relapsing and remitting course, proteinuria and the presence of edema. The PROMIS measures have previously been studied and validated ...